DEERFIELD, Ill.--(BUSINESS WIRE)--Dade Behring Inc. (NASDAQ:DADE) and Premier Inc. have announced the signing of a three-year agreement for Dade Behring’s MicroScan® microbiology instruments and reagents. With the renewal of this microbiology contract, Dade Behring can continue to offer Premier members access to the Company’s entire U.S. clinical diagnostic product portfolio.
